Bo Jiang

Title: Bo Jiang: Innovator in Pharmaceutical Composition

Introduction

Bo Jiang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for cancer treatment. His work exemplifies the intersection of science and technology in addressing critical health challenges.

Latest Patents

Bo Jiang holds a patent for a pharmaceutical composition of a MEK inhibitor and its preparation method. The patent describes a composition that includes 6-(2-chloro-4-iodophenylamino)-N-(2-hydroxyethoxy)-5-methyl-4-oxo-4,5-dihydrofuro[3,2-c]pyridine-7-carboxamide or a pharmaceutically acceptable salt, along with a binder, a surface stabilizer, and a dispersant. This composition can be dispersed in water to form a pharmaceutical suspension with a median particle size, X50, ranging from 0.5 µm to 4.0 µm. The invention is particularly relevant for treating various cancers, showcasing Jiang's commitment to advancing medical science.

Career Highlights

Bo Jiang is associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has not only contributed to the company's portfolio but has also had a broader impact on cancer treatment methodologies.

Collaborations

Throughout his career, Bo Jiang has collaborated with talented individuals such as Xiongxiong He and Ping Dong. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Bo Jiang's contributions to pharmaceutical innovation, particularly in cancer treatment, highlight his role as a key inventor in the industry. His patent for a MEK inhibitor composition is a testament to his dedication to improving healthcare outcomes.